AbCellera Biologics (ABCL) Return on Sales (2020 - 2026)
AbCellera Biologics' (ABCL) quarterly Return on Sales came in at 0.05% in Q1 2026, up 6.0% YoY from 0.05% in Q1 2025, and down 2503.04% on a QoQ basis from 0.0% in Q4 2025.
AbCellera Biologics (ABCL) Return on Sales (2020 - 2026) Analysis & Trends
AbCellera Biologics (ABCL) has 7 years of Return on Sales data on file, last reported at 0.05% in Q1 2026.
- Quarterly Return on Sales rose 6.0% year-over-year to 0.05% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.02% (up 5.0% YoY) and the FY2025 annual result came in at 0.02%, up 4.0% from the prior year.
- Return on Sales retreated to 0.05% in Q1 2026, from 0.0% in the prior quarter.
- In the past five years, Return on Sales ranged from a high of 0.01% in Q1 2022 to a low of 0.11% in Q1 2025.
- A 5-year average of 0.04% and a median of 0.04% in 2024 frame the typical range for Return on Sales.
- The widest YoY moves for Return on Sales: up 7 bps in 2025, down 7 bps in 2025.
- Tracing ABCL's Return on Sales over 5 years: stood at 0.01% in 2022, then plunged by 270 bps to 0.05% in 2023, then plunged by 32 bps to 0.07% in 2024, then surged by 97 bps to 0.0% in 2025, then tumbled by 2503 bps to 0.05% in 2026.
- The last three Return on Sales figures came in at 0.05% (Q1 2026), 0.0% (Q4 2025), and 0.06% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 0.00% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.00% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.00% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.00% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.00% |
| 10 | AbCellera Biologics | 3.49 Bn | 3.49 Bn | - | -0.14% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.14% |
| Mar 31, 2026 | -0.05% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | -0.06% |
| Jun 30, 2025 | -0.02% |
| Mar 31, 2025 | -0.11% |
| Dec 31, 2024 | -0.07% |
| Sep 30, 2024 | -0.08% |
| Jun 30, 2024 | -0.05% |
| Mar 31, 2024 | -0.04% |
| Dec 31, 2023 | -0.05% |
| Sep 30, 2023 | -0.04% |
| Jun 30, 2023 | -0.03% |
| Mar 31, 2023 | -0.03% |
| Dec 31, 2022 | -0.01% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | 0.01% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | -0.04% |